Skip to content

Medline, Inc. MDLN Medline Brand — Goodwill

Other segment segments

Supply Chain Solutions
$1.35B

Similar metrics at other companies

Boston Scientific logo
BSXMedSurg — Goodwill
$7.98B+6.4%
Solventum logo
SOLVMedSurg — Goodwill
$4.18B+13.9%
Mirion Technologies logo
MIRMedical Segment — Goodwill
$634M0.0%
Stryker logo
SYKMedSurg and Neurotechnology: — Goodwill
$11.95B
Gentherm logo
THRMMedical — Goodwill
$28.01M+3.3%
Varex Imaging Corporation logo
VREXMedical — Goodwill
$173.5M

Other financials

Income statement

See full
Revenue$7.4B+10.7%
Gross profit$1.8B+0.9%
Operating income$422.0M-26.1%
Net income$239.0M-25.1%
EPS (diluted)$0.16

Balance sheet

See full
Cash & equivalents$2.2B+166%
Total debt$12.6B
Total equity$11.3B
Total assets$39.0B

Cash flow

See full
Operating cash flow$412.0M-39.6%
CapEx$96.0M-2.0%
Free cash flow$316.0M-45.9%

Valuation

See full
Market cap$32.87B+5.7%
Enterprise value$43.19B
P/E39.1×
P/S1.2×

Profitability

See full
Gross margin27.4%+1.5pp
Operating margin8.5%+2.3pp
Net margin4.6%+2.7pp
FCF margin6.4%+0.5pp

Returns & leverage

See full
Return on equity7.7%
Debt / equity1.1×
Current ratio4.4×

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's medline brand — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medline, Inc. 's medline brand — goodwill?
Medline, Inc. (MDLN) reported medline brand — goodwill of $6.72B in Q1 2026.
What does medline brand — goodwill mean?
Represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations allocated to the Medline Brand segment. This asset reflects the premium paid for intangible synergies, brand reputation, and market positioning within the medical-surgical product manufacturing business. It is subject to periodic impairment testing to ensure the carrying value remains supported by the segment's future cash flows.